Genomics In Cancer Care Market Growth & Trends
The global genomics in cancer care market size is expected to reach USD 50.97 billion by 2030. It is projected to expand at a CAGR of 16.0% from 2024 to 2030. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.
In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.
Genomics In Cancer Care Market Report Highlights
- Instrument segment dominated the overall market in terms of revenue share as of 2023 and accounted for 54.8% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.
- Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.
- Drug discovery and development segment is expected to show lucrative CAGR of 18.5% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Genomic in Cancer Care Market Variables, Trends, & Scope
Chapter 4. Genomics in Cancer Care Market: Product Estimates & Trend Analysis
Chapter 5. Genomics in Cancer Care Market: Application Estimates & Trend Analysis
Chapter 6. Genomics in Cancer Care Market: Technology Estimates & Trend Analysis
Chapter 7. Genomics in Cancer Care Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Beckman Coulter, Inc.
- Illumina Inc.
- Abbott
- Cancer Genetic Inc.
- Bio-Rad Laboratories, Inc.
- PacBio
- GE Healthcare
- Quest Diagnostics Incorporated
- PerkinElmer
- Luminex
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 18.12 Billion |
| Forecasted Market Value ( USD | $ 50.97 Billion |
| Compound Annual Growth Rate | 16.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
